The role of 5-HT1A autoreceptors and α 1-Adrenoceptors in the inhibition of 5-HT release—II NAN-190 and SDZ 216-525

[1]  I A Cliffe,et al.  A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. , 1995, European journal of pharmacology.

[2]  S. Hjorth,et al.  Studies on the role of 5-HT1A autoreceptors and α 1-adrenoceptors in the inhibition of 5-HT release—I. BMY7378 and prazosin , 1995, Neuropharmacology.

[3]  C. Dourish,et al.  Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190. , 1995, European journal of pharmacology.

[4]  C. Dourish,et al.  In vivo characterization of the putative 5-HT1A receptor antagonist SDZ 216,525 using two models of somatodendritic 5-HT1A receptor function , 1994, Neuropharmacology.

[5]  C. Marsden,et al.  Effect of the putative 5-HT1A antagonists WAY100135 and SDZ 216—525 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleus , 1994, Neuropharmacology.

[6]  M. Millan,et al.  Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists. , 1994, The Journal of pharmacology and experimental therapeutics.

[7]  R. Mccall,et al.  Characterization of the serotonin1A receptor antagonist activity of WAY-100135 and spiperone. , 1994, The Journal of pharmacology and experimental therapeutics.

[8]  C. Dourish,et al.  Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents. , 1993, Trends in pharmacological sciences.

[9]  S. Haj-Dahmane,et al.  Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525. , 1993, European journal of pharmacology.

[10]  C. Dourish,et al.  Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study. , 1993, European journal of pharmacology.

[11]  J. Fozard,et al.  The novel 5‐HT1A receptor antagonist, SDZ 216–525, decreases 5‐HT release in rat hippocampus in vivo , 1993, British journal of pharmacology.

[12]  Y. Reilly,et al.  WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors. , 1993, European journal of pharmacology.

[13]  S. Hjorth,et al.  In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol. , 1993, The Journal of pharmacology and experimental therapeutics.

[14]  J. Fozard,et al.  SDZ 216-525, a selective and potent 5-HT1A receptor antagonist. , 1993, European journal of pharmacology.

[15]  C. Dourish,et al.  Effects of the putative 5-HT1A receptor antagonist NAN-190 on free feeding and on feeding induced by the 5-HT1A receptor agonist 8-OH-DPAT in the rat. , 1992, European journal of pharmacology.

[16]  F. Yocca,et al.  Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes. , 1992, Molecular pharmacology.

[17]  J. Greuel,et al.  The putative 5-HT1A receptor antagonists NAN-190 and BMY 7378 are partial agonists in the rat dorsal raphe nucleus in vitro. , 1992, European journal of pharmacology.

[18]  J. Stamford,et al.  Monitoring neuronal activity : a practical approach , 1992 .

[19]  Y. Claustre,et al.  Effect of the putative 5-HT1A receptor antagonist NAN-190 on rat brain serotonergic transmission. , 1991, European journal of pharmacology.

[20]  S. Hjorth,et al.  Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor , 1990, Journal of Neuroscience Methods.

[21]  B. Budziszewska,et al.  The behavioural, but not the hypothermic or corticosterone, response to 8-hydroxy-2-(di-n-propylamino)-tetralin, is antagonized by nan-190 in the rat , 1990, Neuropharmacology.

[22]  D G Grahame-Smith,et al.  Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378. , 1990, European journal of pharmacology.

[23]  M. Goldstein,et al.  Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. , 1990, Molecular pharmacology.

[24]  S. Hjorth,et al.  Mixed agonist/antagonist properties of NAN-190 at 5-HT1A receptors: behavioural and in vivo brain microdialysis studies. , 1990, Life sciences.

[25]  D G Grahame-Smith,et al.  5‐HT1 agonists reduce 5‐hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis , 1989, British journal of pharmacology.

[26]  R. Glennon,et al.  NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). , 1988, European journal of pharmacology.

[27]  G. Aghajanian,et al.  Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists , 1980, Neuropharmacology.